Literature DB >> 27518778

The Challenges of a Successful Pregnancy in a Patient with Adult Refsum's Disease due to Phytanoyl-CoA Hydroxylase Deficiency.

Karolina M Stepien1, Anthony S Wierzbicki2, Bwee T Poll-The3, Hans R Waterham4, Christian J Hendriksz5,6.   

Abstract

We describe the management and outcomes of pregnancy in a 27-year-old woman with infantile-onset Adult Refsum's disease (ARD). She presented in infancy but was diagnosed with ARD at the age of 10 on basis of phytanic acidaemia and later confirmed to have the phytanoyl-CoA hydroxylase ((PHYH) c.164delT, p.L55fsX12) mutation. Despite repeated plasmapheresis sessions and strict dietary surveillance for 20 years, her phytanic acid levels persistently stayed above the ideal target level of 100 μmol/L but remained below 400 μmol/L. Initially the pregnancy was uncomplicated but in the third trimester of pregnancy the patient was admitted to the hospital with fluctuating hypertension, sinus tachycardia and breathlessness. The patient was compliant with diet during pregnancy and her phytanic levels were remained well controlled: 177 and 188 μmol/L in the first and second trimester, respectively. Peri-partum management required a coordinated team approach including a high-calorie and restricted diet to reduce the risk of acute metabolic decompensation. During the induced labour she required 10% dextrose infusions.Post-partum it took the mother a long time to recover from childbirth - her appetite was poor due to post-natal depression and her body weight decreased rapidly by 11 kg within 3 weeks after childbirth, resulting in a spike in phytanic acid to 366 μmol/L. Measures were taken to minimise the risk of acute neurological decompensation. The infant was unaffected and has made normal developmental progress in the subsequent 2 years.

Entities:  

Keywords:  Adult Refsum’s disease; Phytanic acid; Phytanoyl-CoA hydroxylase deficiency; Pregnancy

Year:  2016        PMID: 27518778      PMCID: PMC5413453          DOI: 10.1007/8904_2016_569

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  20 in total

1.  Long-term strategies for the treatment of Refsum's disease using therapeutic apheresis.

Authors:  D Zolotov; S Wagner; K Kalb; J Bunia; A Heibges; R Klingel
Journal:  J Clin Apher       Date:  2012-01-20       Impact factor: 2.821

2.  The effectiveness of long-term dietary therapy in the treatment of adult Refsum disease.

Authors:  Eleanor J Baldwin; F Brian Gibberd; Claire Harley; Margaret C Sidey; Michael D Feher; Anthony S Wierzbicki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-14       Impact factor: 10.154

3.  A series of pregnancies in women with inherited metabolic disease.

Authors:  Janneke G Langendonk; Jonathan C P Roos; Lindsay Angus; Monique Williams; François P J Karstens; Johannes B C de Klerk; Charlé Maritz; Tawfeg Ben-Omran; Catherine Williamson; Robin H Lachmann; Elaine Murphy
Journal:  J Inherit Metab Dis       Date:  2011-09-15       Impact factor: 4.982

Review 4.  Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus.

Authors:  N F Butte
Journal:  Am J Clin Nutr       Date:  2000-05       Impact factor: 7.045

5.  Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum disease.

Authors:  Anthony S Wierzbicki; Phillip D Mayne; Matthew D Lloyd; David Burston; Guam Mei; Margaret C Sidey; Michael D Feher; F Brian Gibberd
Journal:  J Lipid Res       Date:  2003-04-16       Impact factor: 5.922

6.  A child with night blindness: preventing serious symptoms of Refsum disease.

Authors:  Alfried Kohlschütter; René Santer; Zoltan Lukacs; Christiane Altenburg; Markus J Kemper; Klaus Rüther
Journal:  J Child Neurol       Date:  2011-12-07       Impact factor: 1.987

7.  Phytanoyl-CoA hydroxylase activity is induced by phytanic acid.

Authors:  A W Zomer; G A Jansen; B Van Der Burg; N M Verhoeven; C Jakobs; P T Van Der Saag; R J Wanders; B T Poll-The
Journal:  Eur J Biochem       Date:  2000-07

Review 8.  Alpha-methylacyl-CoA racemase--an 'obscure' metabolic enzyme takes centre stage.

Authors:  Matthew D Lloyd; Daniel J Darley; Anthony S Wierzbicki; Michael D Threadgill
Journal:  FEBS J       Date:  2008-02-12       Impact factor: 5.542

9.  Safety of long-term restrictive diets for peroxisomal disorders: vitamin and trace element status of patients treated for Adult Refsum Disease.

Authors:  E J Baldwin; D J Harrington; B Sampson; M D Feher; A S Wierzbicki
Journal:  Int J Clin Pract       Date:  2016-01-22       Impact factor: 2.503

10.  Phytanic acid alpha-oxidase deficiency (Refsum disease) presenting in infancy.

Authors:  M A Herbert; P T Clayton
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

View more
  1 in total

Review 1.  Impact of pregnancy on inborn errors of metabolism.

Authors:  Gisela Wilcox
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.